Back to Journals » Therapeutics and Clinical Risk Management » Volume 7
Diclofenac gel in the treatment of actinic keratoses
Authors Nelson C
Published 15 June 2011 Volume 2011:7 Pages 207—211
DOI https://doi.org/10.2147/TCRM.S12498
Review by Single anonymous peer review
Peer reviewer comments 3
Christopher G Nelson
Department of Dermatology and Cutaneous Surgery, University of South Florida College of Medicine, Tampa, FL, USA
Abstract: Actinic keratoses are areas of intraepithelial neoplasia for which treatment is necessary. Because they arise in areas of sun damage, it is desirable to treat the entire damaged field to not only treat visible lesions, but also subclinical, emerging malignancies, ie, “field therapy”, 5-fluorouracil, imiquimod, and diclofenac are all treatment options, and are discussed and compared.
Keywords: actinic keratosis, topical diclofenac, field therapy, review
© 2011 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.